Clinical trials
Recruiting Myelodysplastic Syndromes trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 2 |
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
| Celgene | 1 |
| Ellipses Pharma | 1 |
| GlaxoSmithKline | 1 |
| Imperial College London | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| Swedish Orphan Biovitrum | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 13 |
| Leukemia, Myeloid, Acute | 7 |
| Leukemia, Myelomonocytic, Chronic | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Anemia | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Multiple Myeloma | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Hematologic Diseases | 1 |
| Hematologic Neoplasms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.